37 / 1084
Response to chemotherapy / CRT
Predict outcome for OG patients
•
responders
to neoadjuvant therapy benefit most post
surgery
•
non-responders
to neoadjuvant therapy have a poorer
prognosis post op than those who have primary
surgery alone*
β
•
Individualise patient care
*Ancona E, Ruol A et al. 2001. Cancer; 91:2165-2174
β
Law S, Fok M et al 1997. J Thorac Cardiovasc Surg; 14: 210-217